Tapinarof Cream 1% Once Daily for Plaque Psoriasis: Long-Term Extension Trial of a Novel Therapeutic Aryl Hydrocarbon Receptor Modulating Agent

Bruce Strober, Linda Stein Gold, Robert Bissonnette, April Armstrong, Andrew Blauvelt, Leon Kircik, Philip M. Brown, Anna M. Tallman, Mark Lebwohl

Research output: Contribution to journalComment/debate

Original languageEnglish
JournalSKIN: Journal of Cutaneous Medicine
Issue number2
StatePublished - 4 Mar 2022

Cite this